Maxvolt Energy Industries Ltd: EV Battery Ka “Duracell Bunny” or Short-Circuit Risk?
1. At a Glance
Maxvolt Energy, born in 2019 and IPO-listed in Feb ’25, is that young EV battery company that wants to run before learning to walk. With sales doubling to ₹107 Cr, PAT at ₹10 Cr, and margins at 13%, the growth story looks like a Tesla Powerwall ad. Stock trades at ₹220 (P/E 23.7x), not dirt-cheap but reasonable versus auto-component peers. The kicker? 91% of revenues come from e-scooter batteries—so if Ola Electric sneezes, Maxvolt catches pneumonia.
2. Introduction
India’s EV boom is like Bollywood sequels—everyone knows half of them will flop, but money keeps pouring in. Into this chaos comes Maxvolt, a Ghaziabad-based lithium-ion battery maker. The company isn’t just selling batteries; it’s selling hope—hope that your e-rickshaw won’t die halfway to Connaught Place.
The IPO in Feb ’25 raised ₹54 Cr. Fresh capital is going into expansion, working capital, and debt repayment. Investors piled in because the words “lithium-ion” and “IPO” together are like catnip in Dalal Street. But now that the post-listing honeymoon is over, real questions remain—can Maxvolt survive with its tiny balance sheet while competing with global suppliers and Indian biggies like Amara Raja, Exide, and Ola’s captive battery projects?
Let me ask you: would you trust a 5-year-old company with your EV battery—or do you prefer brands older than your scooter itself?
3. Business Model – WTF Do They Even Do?
Maxvolt runs a pretty straightforward (read: concentrated) model:
Manufacturing (85% of revenue): Their bread and butter—Li-ion packs for e-scooters, e-rickshaws, cycles, drones, medical gadgets.
Outsourcing (15% of revenue): Lead batteries and chargers designed in-house but outsourced to vendors. Basically, “branding lagao, margin kamao.”
Product Mix (H1 FY25):
E-Scooter Batteries – 91.5%
Chargers – 4.5%
Others (drones, tools, agri) – 3.5%
E-Rickshaw – 0.5% (no love for the rickshaws).
Distribution is dealer-heavy (88%), OEM contribution is just 12%. Top 5 customers = 74% of revenue. That’s concentration on steroids—lose two clients, and it’s lights out.
4. Financials Overview
Source table
Metric
Mar ’25 (Q4)
Mar ’24 (YoY)
Dec ’24 (QoQ)
YoY %
QoQ %
Revenue
₹67.2 Cr
₹27.5 Cr
₹28 Cr
+144%
+140%
EBITDA
₹9.0 Cr
₹3.8 Cr
₹6.0 Cr
+137%
+50%
PAT
₹5.34 Cr
₹3.99 Cr
₹4.0 Cr
+34%
+33%
EPS (₹)
4.90
3.75
5.14
+31%
-5%
Commentary: Sales growing like India’s EV hype cycle, but PAT margins remain slim. Annualised EPS ~₹19, implying forward P/E ~11.5x. Reasonable—if growth sustains.
